Abstract
For the determination of the mutation rate of a single gene it is necessary to screen a very large number of the individual units chosen as testing objects. Single cell systems have been developed making possible the effective scoring of billions of cells in a short time. The mutants observed and counted are clones, originating from a single mutant cell. Most of the methods having microorganisms as testing objects use selective media in which only the mutants can grow out to colonies large enough to be scored by the naked eye. The same principles have been applied to mammalian cells, transformed to grow continuously, e.g., cell lines of Chinese hamster or humans. Results from such mutation tests are used for the risk evaluation of human exposure to genotoxic agents. However, the information gained in such tests about the genotoxic effects of a chemical in humans has limited value, mainly because human pharmacokinetic and metabolic factors are difficult to mimic. Therefore, there is great potential value in a mutation test performed with human cells constructed so that mutation can occur in vivo, the indicator cells can be withdrawn, and the mutant character can be developed in vitro.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
K. C. Atwood, The presence of A2 erythrocytes T in Ax blood, Proc. Natl. Acad. Sci. USA, 44:1054– 1057 (1958).
K. C. Atwood and S. L. Scheinberg, Somatic variation in human erythrocyte antigens, J. Cell Comp. Phys., 52:97–123 (1958).
H. E. Sutton, Monitoring of somatic mutations in human populations, in: Mutagenic Effects on Environmental Contaminants (E. H. Sutton and M. I. Harris, eds.), Academic Press, New York, pp. 121–128 (1972).
H. E. Sutton, Somatic cell mutations, in: Birth Defects; Proceedings 4th International Conference (A. G. Motulsky and W. Lenz, eds.), Exerpta Medica, Amsterdam, pp. 212–214 (1974).
T. Papayannopoulou, T. C. McGuire, G. Lim, E. Garzel, P. E. Nute, and G. Stamatoyannopoulos, Identification of haemoglobin S in red cells and normoblasts, using fluorescent anti-Hb S antibodies, Br. J. Haematol., 34:25–31 (1976).
W. L. Bigbee, E. W. Branscomb, H. B. Weintraub, Th. Papayannopoulou, and G. Stamatoyannopoulos, Cell sorter immunofluorescence detection of human erythrocytes labeled in suspension with antibodies specific for hemoglobin S and C, J. Immunol. Methods, 45:117–127 (1981).
G. H. Strauss and R. J. Albertini, 6-Thioguanine resistant lymphocytes in human peripheral blood, in: Progress in Genetic Toxicology (D. Scott, B. A. Bridges, and F. H. Sobels, eds.), Elsevier/North Holland, Amsterdam, pp. 327–334 (1977).
G. H. Strauss and R. J. Albertini, Enumeration of 6-thioguan- ine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arisingin vivo, Mutat. Res., 61:353–379 (1979).
H. J. Evans and Vijayalaxmi, Induction of 8-azaguanine resistance and sister chromatid exchange in human lymphocytes exposed to mitomycin C and X raysin vitro, Nature, 292:601–605 (1981).
H. Amn£us, P. Matsson, and G. Zetterberg, Human lymphocytes resistant to 6-thioguanine: Restrictions in the use of a test for somatic mutations arisingin vivostudied by flow-cytom- etric enrichment of resistant cell nuclei, Mutat. Res., 106: 163–178 (1982).
C. T. Caskey and G. D. Kruh, The HPRT locus, Cell, 16:1–9 (1979).
R. DeMars, Genetic studies of HGPRT-deficiency and the Lesch- Nyhan syndrome with cultured human cells, Fed. Proc., 30:944–955 (1971).
R. DeMars, Resistance of cultured human fibroblasts and other cells to purine and pyrimidine analogoues in relation to mutagenesis detection, Mutat. Res., 24:335–364 (1974).
H. N. Kelley, Enzymology and biochemistry, A. HG-PRT deficiency in the Lesch-Nyhan syndrome and gout, Fed. Proc., 27:1047–1052 (1968).
P. Stutts and R. W. Brockman, A biochemical basis for resistance of L 1210 mouse leukeran to 6-thioguanin, Biochem. Pharmacol., 12:97–104 (1963).
G. B. Elion and G. H. Hitchings, Metabolic basis for the ac¬tions of analogs of purines and pyrimidines, in: Advances in Chemotheraphy (A. Goldin, F. Hawkin, and R. J. Schnitzer, eds.), Vol. 2, pp. 91–97, Academic Press, New York (1965).
G. B. Elion, Biochemistry and pharmacology of purine analogs, Fed. Proc., 26:898–904 (1967).
R. P. Miech, R. E. Parks, Jr., J. H. Anderson, Jr., and A. C. Sartorelli, A hypothesis on the mechanism of action of 6-thio- guanine, Biochem. Pharmacol., 16:2222–2227 (1967).
J. Arly-Nelson, J. W. Carpenter, L. M. Rose, and D. J. Adamson, Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine, Cancer Res., 35:2872–2878 (1975).
M. Lesch and W. L. Nyhan, A familial disorder or uric acid metabolism and control nervous system function, Am. J. Med., 36:561–570 (1964).
J. E. Seegmiller, F. M. Rosenbloom, and W. N. Kelley, Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis, Science, 155:1682–1684 (1967).
C. H. M. M. de Bryun, Hypoxanthine-guanine phosphoribosyl- transferase deficiency, Human Genet., 31:127–150 (1976).
L. B. Vogler, C. E. Grossi, and M. D. Cooper, Human lymphocyte subpopulations, Progress in Hematology, 11:1–45 (1979).
R. J. Albertini, E. F. Allen, A. S. Quinn, M. R. Albertini, Human somatic cell mutation:In vivovariant lymphocyte frequencies as determined by 6-thioguanine resistance, in: Population and Biological Aspects of Human Mutation (E. B. Hook and J. H. Porter, eds.), pp. 235–263, Academic Press, New York (1981).
R. P. Wagner and H. K. Mitchell, in: Genetics and Metabolism, 2nd ed., John Wiley and Sons, Inc., New York (1964).
. R. J. Albertini and W. R. Borcherding, Cloningin vitroof human 6-thioguanine resistant (TGr) peripheral blood lymphocytes (PBL’s) arisingin vivo, Abstract 13th Ann. Mtg. Environ. Mutagen Society, Environ. Mutag. (in press) (1982).
. R. J. Albertini, STudies with T-lymphocytes: An approach to human mutagenicity monitoring, in: Indicators of Genotoxic Exposure (B. A. Bridges, B. E. Butterworth, and I. B. Weinstein, eds.), Banbury Report, 13:393–412, Cold Spring Harbor Laboratory (1982).
G. H. S. Strauss, Direct mutagenicity testing: The development of a clonal assay to detect and quantitate mutant lymphocytes arising in vivo, in: Indicators of Genotoxic Exposure (B. A. Bridges, B. E. Butterworth, and I. B. Weinstein, eds.), Banbury Report, 13:423–441, Cold Spring Harbor Laboratory (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Zetterberg, G. (1984). Peripheral Blood Lymphocytes as Indicator Cells for in vivo Mutation in Man. In: de Serres, F.J., Pero, R.W. (eds) Individual Susceptibility to Genotoxic Agents in the Human Population. Environmental Science Research, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2765-3_15
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2765-3_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9709-3
Online ISBN: 978-1-4613-2765-3
eBook Packages: Springer Book Archive